Haisco Pharmaceutical Group Co., Ltd.: all 155 studies

Page 2 of 2. Open to participants first (49), then studies with results posted, then the rest; newest registration first within each.

• A Study of HSK31858 in Participants with Non-Cystic Fibrosis BronchiectasisCompletedNCT05601778Phase 2
• Ascending Single-Dose and Multiple-Dose Study to Evaluate HSK31679 in Healthy Subjects and Subjects With Elevated LDL-CCompletedNCT05531097Phase 1
• A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal ImpairmentCompletedNCT05497297Phase 1
• A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain TreatmentCompletedNCT05390905Phase 3
• Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPNCompletedNCT05319275Phase 3
• Drug-drug Interaction Between Ciprofol and Mefanamic Acid or ValproateCompletedNCT05181007Phase 1
• To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Postherpetic NeuralgiaCompletedNCT05140863Phase 3
• A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients with Chronic Kidney Disease-Associated PruritusCompletedNCT05135390Phase 3
• Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVRStatus unknownNCT05035069Phase 4
• A Study of Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosed of HSK31858 in Healthy VolunteersCompletedNCT05023525Phase 1
• A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With PruritusCompletedNCT04999787Phase 2
• Phase III Clinical Trial Evaluating the Efficacy and Safety of Ciprofol Injection for the Induction of Sedation/Anesthesia in Subjects Undergoing Gynecological Outpatient SurgeriesCompletedNCT04958746Phase 3
• A Study of HSK29116 in Adults With Relapsed/Refractory B-cell MalignanciesStatus unknownNCT04861779Phase 1
• A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride TabletsStatus unknownNCT04841720Phase 1
• A Clinical Study to Evaluate Efficacy and Safety of HSK21542 for Postoperative Analgesia of Subjects Undergoing Elective Laparoscopic Surgery Under General AnesthesiaCompletedNCT04738357Phase 3
• HSK7653 in Chinese Patients with Impaired Glucose ToleranceCompletedNCT04727580Phase 2
• Safety, Tolerability and Pharmacokinetics of FTP-198 Tablet in Healthy Chinese VolunteersCompletedNCT04687813Phase 1
• A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical VentilationCompletedNCT04669821Phase 2
• To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic PainStatus unknownNCT04647773Phase 2/3
• A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Undergoing Mechanical VentilationCompletedNCT04620031Phase 3
• Efficacy and Safety of Polyene Phosphatidylcholine in Treatment of Patients With Acute Drug-induced Liver InjuryCompletedNCT04595916Phase 4
• HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes MellitusCompletedNCT04564872Phase 3
• HSK7653 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCompletedNCT04556851Phase 3
• A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on After Meals in Healthy SubjectsCompletedNCT04556110Phase 1
• A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy SubjectsCompletedNCT04556058Phase 1
• Mass Balance and Biotransformation of [14C]HSK7653 in HumanCompletedNCT04540016Phase 1
• Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian VolunteersCompletedNCT04526496Phase 1
• A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General AnesthesiaCompletedNCT04511728Phase 3
• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing HemodialysisCompletedNCT04470154Phase 2
• A Study Evaluating the Efficacy and Safety of HSK21542 Injection for Analgesia in Subjects Undergoing ColonoscopyCompletedNCT04470128Phase 2
• Efficacy and Safety of HSK21542 in Inducing Postoperative Analgesia in Undergoing Elective Laparoscopic SurgeryCompletedNCT04424251Phase 2
• A Study to Evaluate the Differences in Pharmadynamics, Pharmacokinetics, and Safety Between Ciprofol and PropofolCompletedNCT04294056Phase 1
• Safety, Tolerability and Pharmacokinetics of HSK21542 in Healthy VolunteersCompletedNCT04213196Phase 1
• Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Healthy Elderly SubjectsCompletedNCT04197661Phase 1
• A Study Evaluating the Efficacy and Safety of HSK3486 for SedationCompletedNCT04147416Phase 2
• Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Hepatic ImpairmentCompletedNCT04145596Phase 1
• A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole TabletsCompletedNCT04145583Phase 1
• Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal FunctionsCompletedNCT04142970Phase 1
• A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Subjects Undergoing Fiberoptic BronchoscopyCompletedNCT04111159Phase 3
• Safety, Tolerability, and Pharmacokinetics of HSK21542 in Healthy VolunteersCompletedNCT04110886Phase 1
• A Study Evaluating Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 and Etomidate for Induction of Anesthesia in Healthy Male SubjectsCompletedNCT04054063Phase 1
• A Clinical Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Elective Surgery PatientsCompletedNCT04048811Phase 2
• Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Female Subjects.CompletedNCT04037657Phase 1
• A Study Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Subjects.CompletedNCT04033939Phase 1
• A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male SubjectsCompletedNCT04029766Phase 1
• A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion for the Induction of General Anesthesia in Elective Surgery SubjectsCompletedNCT03808844Phase 3
• A Study Evaluating Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Single IV Dose of HSK3486 Injectable Emulsion in Healthy Subjects.CompletedNCT03773835Phase 1
• A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in PatientsCompletedNCT03773042Phase 2
• A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin CapsulesCompletedNCT03758469Phase 1
• A Study Evaluating the Mass Balance of Micro-dose[14C]HSK3486 Emulsion Injection in Healthy AdultsWithdrawnNCT03751969Phase 1
• A Study Evaluating the Mass Balance of [14C]HSK3486 Emulsion Injection in Healthy Adults.CompletedNCT03751956Phase 1
• A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486CompletedNCT03745625Phase 1
• A Study Evaluating the Efficacy and Safety of HSK3486CompletedNCT03709056Phase 2
• A Phase IIa Study Investigating the Tolerance, Efficacy and Safety of HSK3486CompletedNCT03698617Phase 2
• A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or AnesthesiaCompletedNCT03674008Phase 3

← Haisco Pharmaceutical Group Co., Ltd. overview and focus areas